@prefix ns1: <http://example.org/relation/> .
@prefix ns2: <http://example.org/> .

<http://example.org/doc/samplepdf> a ns2:Document ;
    ns2:contains <http://example.org/entity/ASCR_procedure>,
        <http://example.org/entity/AVD150_treatment_regimen>,
        <http://example.org/entity/AVD250_treatment_regimen>,
        <http://example.org/entity/AVD_Treatment_Combination>,
        <http://example.org/entity/AVD_Treatment_Group>,
        <http://example.org/entity/AV_2_Treatment_Group>,
        <http://example.org/entity/AV_Treatment_Combination>,
        <http://example.org/entity/Actinomycin_D_Drug>,
        <http://example.org/entity/Adult_Wilms_Tumors_medical_condition>,
        <http://example.org/entity/Albania_Country>,
        <http://example.org/entity/Algeria_Country>,
        <http://example.org/entity/Andorra_Country>,
        <http://example.org/entity/Armand_Trousseau_Hospital_Institution>,
        <http://example.org/entity/Aronson_et_al_Research_Group>,
        <http://example.org/entity/Austria_Country>,
        <http://example.org/entity/Azienda_Ospedaliera_Institution>,
        <http://example.org/entity/Belarus_Country>,
        <http://example.org/entity/Belgium_Country>,
        <http://example.org/entity/Bellani_F_F_author>,
        <http://example.org/entity/Bilateral_Disease_Stage_V_Disease_Stage>,
        <http://example.org/entity/Bilateral_nephron_sparing_surgery_NSS_Treatment_Method>,
        <http://example.org/entity/Bosnia_and_Herzegovina_Country>,
        <http://example.org/entity/Breslow_N_E_author>,
        <http://example.org/entity/Bulgaria_Country>,
        <http://example.org/entity/CCSK_Disease>,
        <http://example.org/entity/CDCV_treatment_regimen>,
        <http://example.org/entity/CMN_Disease>,
        <http://example.org/entity/COGNWTS_trials_trial>,
        <http://example.org/entity/COG_AREN0533_trial_study>,
        <http://example.org/entity/COG_National_Wilms_Tumor_Study_Group_NWTS_4_and_NWTS_5_trials_study>,
        <http://example.org/entity/CT_diagnostic_tool>,
        <http://example.org/entity/CT_only_nodules_medical_condition>,
        <http://example.org/entity/Carboplatin_Drug>,
        <http://example.org/entity/Childrens_Oncology_Group_COG_Organization>,
        <http://example.org/entity/Childrens_Oncology_Group_organization>,
        <http://example.org/entity/Croatia_Country>,
        <http://example.org/entity/Cyclophosphamide_Drug>,
        <http://example.org/entity/Czech_Republic_Country>,
        <http://example.org/entity/DAngio_G_J_author>,
        <http://example.org/entity/Davila_Fajardo_et_al_author>,
        <http://example.org/entity/Daw_N_C_author>,
        <http://example.org/entity/Denmark_Country>,
        <http://example.org/entity/Department_of_Paediatric_Oncology_Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_Institution>,
        <http://example.org/entity/Dix_D_B_author>,
        <http://example.org/entity/Dome_J_S_author>,
        <http://example.org/entity/Doxorubicin_Drug>,
        <http://example.org/entity/End_stage_renal_disease_ESRD_Condition>,
        <http://example.org/entity/Estonia_Country>,
        <http://example.org/entity/Etoposide_Drug>,
        <http://example.org/entity/Event_Free_Survival_EFS_Subject>,
        <http://example.org/entity/Event_Free_Survival_EFS_metric>,
        <http://example.org/entity/ExPOrNet_Project>,
        <http://example.org/entity/Faculty_of_Medicine_Institution>,
        <http://example.org/entity/Finland_Country>,
        <http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Institution>,
        <http://example.org/entity/France_Country>,
        <http://example.org/entity/Furtwangler_R_author>,
        <http://example.org/entity/Germany_Country>,
        <http://example.org/entity/Graf_N_author>,
        <http://example.org/entity/Great_Ormond_Street_Hospital_Institution>,
        <http://example.org/entity/Greece_Country>,
        <http://example.org/entity/Green_D_M_author>,
        <http://example.org/entity/Group_AA_Patient_Group>,
        <http://example.org/entity/Group_BB_Patient_Group>,
        <http://example.org/entity/Group_CC_Patient_Group>,
        <http://example.org/entity/Grundy_P_E_author>,
        <http://example.org/entity/HR_1_Treatment_Combination>,
        <http://example.org/entity/Ha_T_C_author>,
        <http://example.org/entity/High_dose_melphalan_Treatment_Method>,
        <http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Institution>,
        <http://example.org/entity/Hospital_Vall_dHebron_Institution>,
        <http://example.org/entity/Hungary_Country>,
        <http://example.org/entity/Iceland_Country>,
        <http://example.org/entity/Ifosfamide_Drug>,
        <http://example.org/entity/Infant_Wilms_Tumors_medical_condition>,
        <http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_organization>,
        <http://example.org/entity/Ireland_Country>,
        <http://example.org/entity/Italy_Country>,
        <http://example.org/entity/Kremens_B_author>,
        <http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Institution>,
        <http://example.org/entity/Latvia_Country>,
        <http://example.org/entity/Liechtenstein_Country>,
        <http://example.org/entity/Lithuania_Country>,
        <http://example.org/entity/LogRank_P_Statistical_Test>,
        <http://example.org/entity/Luxembourg_Country>,
        <http://example.org/entity/MRI_diagnostic_tool>,
        <http://example.org/entity/MRTK_Disease>,
        <http://example.org/entity/Macedonia_Country>,
        <http://example.org/entity/Malta_Country>,
        <http://example.org/entity/Marciniak_Hospital_Institution>,
        <http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_Person>,
        <http://example.org/entity/Mitchell_C_author>,
        <http://example.org/entity/Moldova_Country>,
        <http://example.org/entity/Monaco_Country>,
        <http://example.org/entity/Montenegro_Country>,
        <http://example.org/entity/Morocco_Country>,
        <http://example.org/entity/NWTS5_relapse_protocol_Treatment_Protocol>,
        <http://example.org/entity/National_Wilms_Tumor_Studies_study>,
        <http://example.org/entity/National_Wilms_Tumor_Study_Group_organization>,
        <http://example.org/entity/Nephron_sparing_surgery_NSS_surgical_procedure>,
        <http://example.org/entity/Netherlands_Country>,
        <http://example.org/entity/Ninth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_study>,
        <http://example.org/entity/Norway_Country>,
        <http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Institution>,
        <http://example.org/entity/Overall_Survival_OS_Subject>,
        <http://example.org/entity/Overall_Survival_OS_metric>,
        <http://example.org/entity/Poland_Country>,
        <http://example.org/entity/Portugal_Country>,
        <http://example.org/entity/Prinses_Maxima_Centrum_Institution>,
        <http://example.org/entity/Pritchard_Jones_K_author>,
        <http://example.org/entity/RCC_Disease>,
        <http://example.org/entity/Relapsed_Wilms_Tumor_Disease_State>,
        <http://example.org/entity/Romania_Country>,
        <http://example.org/entity/Russia_Country>,
        <http://example.org/entity/SIOP2001_Protocol>,
        <http://example.org/entity/SIOP2001_Trial>,
        <http://example.org/entity/SIOP2001_protocol>,
        <http://example.org/entity/SIOP2001_randomized_trial_Clinical_Trial>,
        <http://example.org/entity/SIOP2001_study_Study>,
        <http://example.org/entity/SIOP2001_study_protocol>,
        <http://example.org/entity/SIOPRTSG_Organization>,
        <http://example.org/entity/SIOPRTSG_analysis_study>,
        <http://example.org/entity/SIOPRTSG_board_organization>,
        <http://example.org/entity/SIOPRTSG_organization>,
        <http://example.org/entity/SIOPRTSG_panel_organization>,
        <http://example.org/entity/SIOP_9301_trial_trial>,
        <http://example.org/entity/SIOP_9GPOH_study>,
        <http://example.org/entity/SIOP_RTSG_2016_Protocol>,
        <http://example.org/entity/SIOP_WT_2001_protocol_protocol>,
        <http://example.org/entity/SIOP_database_database>,
        <http://example.org/entity/SIOP_trial_and_study_9301_study>,
        <http://example.org/entity/San_Marino_Country>,
        <http://example.org/entity/Second_National_Wilms_Tumor_Study_study>,
        <http://example.org/entity/Serbia_Country>,
        <http://example.org/entity/Sixth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_study>,
        <http://example.org/entity/Slovakia_Country>,
        <http://example.org/entity/Slovenia_Country>,
        <http://example.org/entity/Smets_A_M_author>,
        <http://example.org/entity/Spain_Country>,
        <http://example.org/entity/Spreafico_F_author>,
        <http://example.org/entity/St_Anna_KinderspitalCCRI_Institution>,
        <http://example.org/entity/Stage_III_Stage>,
        <http://example.org/entity/Stage_II_Stage>,
        <http://example.org/entity/Stage_IV_Stage>,
        <http://example.org/entity/Stage_I_Stage>,
        <http://example.org/entity/Stage_V_Stage>,
        <http://example.org/entity/Sweden_Country>,
        <http://example.org/entity/Switzerland_Country>,
        <http://example.org/entity/Synchronous_bilateral_Wilms_tumor_Disease>,
        <http://example.org/entity/The_Renal_Tumour_Study_Group_of_the_International_Society_of_Paediatric_Oncology_SIOPRTSG_Organization>,
        <http://example.org/entity/Third_National_Wilms_Tumor_Study_study>,
        <http://example.org/entity/Tournade_M_F_author>,
        <http://example.org/entity/Tunisia_Country>,
        <http://example.org/entity/Turkey_Country>,
        <http://example.org/entity/UKW3_trial>,
        <http://example.org/entity/UKW3_trial_Clinical_Trial>,
        <http://example.org/entity/UKWR_protocol_Treatment_Protocol>,
        <http://example.org/entity/UK_Childrens_Cancer_Study_Group_organization>,
        <http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_Organization>,
        <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_Project>,
        <http://example.org/entity/UMBRELLA_protocol_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_Treatment_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_protocol_treatment_protocol>,
        <http://example.org/entity/Ukraine_Country>,
        <http://example.org/entity/United_Kingdom_Country>,
        <http://example.org/entity/University_Hospital_Homburg_Institution>,
        <http://example.org/entity/University_Hospital_of_Munich_Institution>,
        <http://example.org/entity/University_Hospital_of_Tuebingen_Institution>,
        <http://example.org/entity/VP16_medication>,
        <http://example.org/entity/Verschuur_A_author>,
        <http://example.org/entity/Vincristine_Drug>,
        <http://example.org/entity/Warmann_S_W_author>,
        <http://example.org/entity/Weirich_A_author>,
        <http://example.org/entity/Wilms_Tumour_Disease>,
        <http://example.org/entity/Wilms_tumours_Condition>,
        <http://example.org/entity/Wilms_tumours_Disease>,
        <http://example.org/entity/Wilms_tumours_condition>,
        <http://example.org/entity/actinomycin_D_Drug>,
        <http://example.org/entity/actinomycin_D_Treatment>,
        <http://example.org/entity/actinomycin_D_drug>,
        <http://example.org/entity/actinomycin_D_medication>,
        <http://example.org/entity/anaplasia_medical_condition>,
        <http://example.org/entity/arnauldverschuurap_hmfr_contact>,
        <http://example.org/entity/bilateral_disease_Disease_Stage>,
        <http://example.org/entity/blastemal_type_Wilms_tumours_Subtype>,
        <http://example.org/entity/blastemal_type_tumors_condition>,
        <http://example.org/entity/camptothecins_medication_class>,
        <http://example.org/entity/carboplatin_Treatment>,
        <http://example.org/entity/carboplatin_drug>,
        <http://example.org/entity/carboplatin_medication>,
        <http://example.org/entity/chemotherapy_Treatment_Method>,
        <http://example.org/entity/chemotherapy_treatment_method>,
        <http://example.org/entity/childhood_renal_tumours_Disease>,
        <http://example.org/entity/clear_cell_sarcoma_of_the_kidney_Disease>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_Disease>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_medical_condition>,
        <http://example.org/entity/cumulative_doxorubicin_dose_treatment_detail>,
        <http://example.org/entity/cyclophosphamide_Treatment>,
        <http://example.org/entity/cyclophosphamide_drug>,
        <http://example.org/entity/cyclophosphamide_medication>,
        <http://example.org/entity/de_Kraker_J_author>,
        <http://example.org/entity/diffuse_anaplasia_condition>,
        <http://example.org/entity/dosimetric_study_study>,
        <http://example.org/entity/doxorubicin_Drug>,
        <http://example.org/entity/doxorubicin_Treatment>,
        <http://example.org/entity/doxorubicin_drug>,
        <http://example.org/entity/doxorubicin_medication>,
        <http://example.org/entity/etoposide_Treatment>,
        <http://example.org/entity/etoposide_drug>,
        <http://example.org/entity/etoposide_medication>,
        <http://example.org/entity/high_dose_chemotherapy_and_autologous_stem_cell_transplantation_treatment>,
        <http://example.org/entity/high_risk_characteristics_medical_condition>,
        <http://example.org/entity/high_risk_disease_condition_category>,
        <http://example.org/entity/high_risk_risk_category>,
        <http://example.org/entity/ifosfamide_medication>,
        <http://example.org/entity/intermediate_risk_disease_condition_category>,
        <http://example.org/entity/intermediate_risk_risk_category>,
        <http://example.org/entity/irinotecan_medication>,
        <http://example.org/entity/laparoscopic_surgery_surgery_type>,
        <http://example.org/entity/localized_disease_Disease_Stage>,
        <http://example.org/entity/locoregional_disease_condition>,
        <http://example.org/entity/low_risk_disease_condition_category>,
        <http://example.org/entity/low_risk_risk_category>,
        <http://example.org/entity/lymph_node_sampling_surgical_procedure>,
        <http://example.org/entity/major_rupture_condition>,
        <http://example.org/entity/malignant_rhabdoid_tumors_medical_condition>,
        <http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_Disease>,
        <http://example.org/entity/metastatic_disease_Disease_Stage>,
        <http://example.org/entity/metastatic_disease_condition>,
        <http://example.org/entity/minimally_invasive_surgery_surgery_type>,
        <http://example.org/entity/nephrectomy_surgical_procedure>,
        <http://example.org/entity/nephron_sparing_surgery_NSS_surgery_type>,
        <http://example.org/entity/nephrotoxicity_condition>,
        <http://example.org/entity/non_Wilms_tumours_Disease>,
        <http://example.org/entity/proton_therapy_treatment>,
        <http://example.org/entity/pulmonary_radiotherapy_treatment>,
        <http://example.org/entity/radical_tumor_nephrectomy_surgical_procedure>,
        <http://example.org/entity/radiotherapy_Treatment_Method>,
        <http://example.org/entity/radiotherapy_treatment>,
        <http://example.org/entity/radiotherapy_treatment_method>,
        <http://example.org/entity/relapsed_disease_Disease_Stage>,
        <http://example.org/entity/relapsed_group_CC_patient_group>,
        <http://example.org/entity/renal_cell_carcinoma_Disease>,
        <http://example.org/entity/stage_III_stage>,
        <http://example.org/entity/stage_II_stage>,
        <http://example.org/entity/stage_IV_WT_condition>,
        <http://example.org/entity/stage_I_stage>,
        <http://example.org/entity/surgery_Treatment_Method>,
        <http://example.org/entity/surgery_treatment_method>,
        <http://example.org/entity/surgical_excision_treatment_method>,
        <http://example.org/entity/topotecan_medication>,
        <http://example.org/entity/van_den_Heuvel_Eibrink_M_M_author>,
        <http://example.org/entity/vincristine_Drug>,
        <http://example.org/entity/vincristine_Treatment>,
        <http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment>,
        <http://example.org/entity/vincristine_and_actinomycin_D_treatment>,
        <http://example.org/entity/vincristine_drug>,
        <http://example.org/entity/vincristine_irinotecan_cyclophosphamide_carboplatin_etoposide_and_doxorubicin_treatment>,
        <http://example.org/entity/vincristine_medication>,
        <http://example.org/entity/whole_lung_irradiation_treatment>,
        <http://example.org/entity/wwwsiop_rtsgeu_Website> .

<http://example.org/entity/AVD150_entity> ns1:includes <http://example.org/entity/actinomycin_D_entity>,
        <http://example.org/entity/doxorubicin_entity>,
        <http://example.org/entity/vincristine_entity> .

<http://example.org/entity/AVD250_entity> ns1:includes <http://example.org/entity/actinomycin_D_entity>,
        <http://example.org/entity/doxorubicin_entity>,
        <http://example.org/entity/vincristine_entity> .

<http://example.org/entity/AVD_entity> ns1:used_for <http://example.org/entity/Stage_III_entity> .

<http://example.org/entity/AV_entity> ns1:used_for <http://example.org/entity/Stage_II_entity> .

<http://example.org/entity/Adult_Wilms_Tumors_entity> ns1:associated_with <http://example.org/entity/anaplasia_entity> ;
    ns1:treatment_includes <http://example.org/entity/actinomycin_D_entity>,
        <http://example.org/entity/doxorubicin_entity>,
        <http://example.org/entity/vincristine_entity> .

<http://example.org/entity/Aronson_et_al_entity> ns1:observed_effectiveness_of <http://example.org/entity/Bilateral_nephron_sparing_surgery_NSS_entity> .

<http://example.org/entity/Austria_entity> ns1:has <http://example.org/entity/St_Anna_KinderspitalCCRI_entity> .

<http://example.org/entity/Breslow_N_E_entity> ns1:reported_in <http://example.org/entity/National_Wilms_Tumor_Studies_entity> .

<http://example.org/entity/CDCV_entity> ns1:includes <http://example.org/entity/VP16_entity>,
        <http://example.org/entity/carboplatin_entity>,
        <http://example.org/entity/cyclophosphamide_entity>,
        <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/CMN_entity> ns1:included_in <http://example.org/entity/SIOP_RTSG_2016_entity> .

<http://example.org/entity/COGNWTS_trials_entity> ns1:informed_dosage_for <http://example.org/entity/whole_lung_irradiation_entity> .

<http://example.org/entity/CT_only_nodules_entity> ns1:associated_with <http://example.org/entity/increased_relapse_risk_entity>,
        <http://example.org/entity/reduced_survival_entity> ;
    ns1:included_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/Childrens_Oncology_Group_COG_entity> ns1:collaborated_with <http://example.org/entity/SIOP2001_randomized_trial_entity> .

<http://example.org/entity/DAngio_G_J_entity> ns1:conducted <http://example.org/entity/Second_National_Wilms_Tumor_Study_entity>,
        <http://example.org/entity/Third_National_Wilms_Tumor_Study_entity> .

<http://example.org/entity/Davila_Fajardo_et_al_entity> ns1:analyzed <http://example.org/entity/SIOP2001_entity> .

<http://example.org/entity/Daw_N_C_entity> ns1:conducted_under <http://example.org/entity/Childrens_Oncology_Group_entity> .

<http://example.org/entity/Dix_D_B_entity> ns1:reported_in <http://example.org/entity/Childrens_Oncology_Group_entity> .

<http://example.org/entity/End_stage_renal_disease_ESRD_entity> ns1:associated_with <http://example.org/entity/Bilateral_Disease_Stage_V_entity> .

<http://example.org/entity/ExPOrNet_entity> ns1:is_part_of <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_entity> .

<http://example.org/entity/France_entity> ns1:has <http://example.org/entity/Armand_Trousseau_Hospital_entity> .

<http://example.org/entity/Germany_entity> ns1:has <http://example.org/entity/University_Hospital_of_Munich_entity>,
        <http://example.org/entity/University_Hospital_of_Tuebingen_entity> .

<http://example.org/entity/Graf_N_entity> ns1:studied_in <http://example.org/entity/SIOP_trial_and_study_9301_entity> .

<http://example.org/entity/Green_D_M_entity> ns1:reported_by <http://example.org/entity/National_Wilms_Tumor_Study_Group_entity> .

<http://example.org/entity/Group_AA_entity> ns1:treatment_includes <http://example.org/entity/Carboplatin_entity>,
        <http://example.org/entity/Cyclophosphamide_entity>,
        <http://example.org/entity/Doxorubicin_entity>,
        <http://example.org/entity/Etoposide_entity> .

<http://example.org/entity/Group_BB_entity> ns1:treatment_includes <http://example.org/entity/Carboplatin_entity>,
        <http://example.org/entity/Cyclophosphamide_entity>,
        <http://example.org/entity/Etoposide_entity>,
        <http://example.org/entity/High_dose_melphalan_entity>,
        <http://example.org/entity/Ifosfamide_entity> .

<http://example.org/entity/Grundy_P_E_entity> ns1:reported_by <http://example.org/entity/Childrens_Oncology_Group_entity> .

<http://example.org/entity/HR_1_entity> ns1:used_for <http://example.org/entity/High_risk_blastemal_type_Wilms_tumour_entity> .

<http://example.org/entity/Infant_Wilms_Tumors_entity> ns1:treatment_option <http://example.org/entity/nephrectomy_entity> .

<http://example.org/entity/Italy_entity> ns1:has <http://example.org/entity/Azienda_Ospedaliera_entity>,
        <http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_entity>,
        <http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_entity> .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_entity> ns1:affiliated_with <http://example.org/entity/Department_of_Paediatric_Oncology_Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_entity> .

<http://example.org/entity/Mitchell_C_entity> ns1:under <http://example.org/entity/UK_Childrens_Cancer_Study_Group_entity> .

<http://example.org/entity/NWTS5_relapse_protocol_entity> ns1:applied_to <http://example.org/entity/Relapsed_Wilms_Tumor_entity> .

<http://example.org/entity/Nephron_sparing_surgery_NSS_entity> ns1:classification_developed_by <http://example.org/entity/SIOPRTSG_entity> .

<http://example.org/entity/Netherlands_entity> ns1:has <http://example.org/entity/Prinses_Maxima_Centrum_entity> .

<http://example.org/entity/Poland_entity> ns1:has <http://example.org/entity/Faculty_of_Medicine_entity>,
        <http://example.org/entity/Marciniak_Hospital_entity> .

<http://example.org/entity/Pritchard_Jones_K_entity> ns1:analyzed_in <http://example.org/entity/UKW3_entity> .

<http://example.org/entity/RCC_entity> ns1:included_in <http://example.org/entity/SIOP_RTSG_2016_entity> .

<http://example.org/entity/SIOP2001_study_entity> ns1:used_drug <http://example.org/entity/Actinomycin_D_entity>,
        <http://example.org/entity/Vincristine_entity> .

<http://example.org/entity/SIOPRTSG_board_entity> ns1:suggests <http://example.org/entity/high_dose_chemotherapy_and_autologous_stem_cell_transplantation_entity> .

<http://example.org/entity/SIOP_database_entity> ns1:captures_data_on <http://example.org/entity/regimen_and_outcomes_entity> .

<http://example.org/entity/Spain_entity> ns1:has <http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_entity>,
        <http://example.org/entity/Hospital_Vall_dHebron_entity> .

<http://example.org/entity/Stage_IV_entity> ns1:presents_in <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/Synchronous_bilateral_Wilms_tumor_entity> ns1:instance_of <http://example.org/entity/Bilateral_Disease_Stage_V_entity> .

<http://example.org/entity/Tournade_M_F_entity> ns1:reported_in <http://example.org/entity/Sixth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_entity> ;
    ns1:studied_in <http://example.org/entity/Ninth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_entity> .

<http://example.org/entity/UKWR_protocol_entity> ns1:applied_to <http://example.org/entity/Relapsed_Wilms_Tumor_entity> .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_entity> ns1:conducted <http://example.org/entity/UKW3_trial_entity> .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_entity> ns1:available_on <http://example.org/entity/wwwsiop_rtsgeu_entity> ;
    ns1:developed_by <http://example.org/entity/The_Renal_Tumour_Study_Group_of_the_International_Society_of_Paediatric_Oncology_SIOPRTSG_entity> ;
    ns1:succeeds <http://example.org/entity/SIOP2001_entity> .

<http://example.org/entity/United_Kingdom_entity> ns1:has <http://example.org/entity/Great_Ormond_Street_Hospital_entity> .

<http://example.org/entity/Weirich_A_entity> ns1:studied_in <http://example.org/entity/SIOP_9GPOH_entity> .

<http://example.org/entity/blastemal_type_Wilms_tumour_entity> ns1:treatment_intensified_according_to <http://example.org/entity/SIOP2001_entity> .

<http://example.org/entity/camptothecins_entity> ns1:includes <http://example.org/entity/irinotecan_entity>,
        <http://example.org/entity/topotecan_entity> .

<http://example.org/entity/chemotherapy_entity> ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/congenital_mesoblastic_nephroma_entity> ns1:requires <http://example.org/entity/surgery_alone_entity> .

<http://example.org/entity/de_Kraker_J_entity> ns1:conducted <http://example.org/entity/SIOP_9301_trial_entity> .

<http://example.org/entity/dosimetric_study_entity> ns1:investigated <http://example.org/entity/proton_therapy_entity> .

<http://example.org/entity/high_risk_characteristics_entity> ns1:leads_to <http://example.org/entity/unfavorable_prognosis_entity> .

<http://example.org/entity/ifosfamide_entity> ns1:related_to <http://example.org/entity/nephrotoxicity_entity> .

<http://example.org/entity/laparoscopic_surgery_entity> ns1:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/lymph_node_sampling_entity> ns1:purpose_of <http://example.org/entity/accurate_staging_entity> .

<http://example.org/entity/malignant_rhabdoid_tumors_entity> ns1:requires <http://example.org/entity/alternative_chemotherapy_entity> .

<http://example.org/entity/minimally_invasive_surgery_entity> ns1:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/non_Wilms_tumours_entity> ns1:category_of <http://example.org/entity/childhood_renal_tumours_entity> .

<http://example.org/entity/pulmonary_radiotherapy_entity> ns1:administered_for <http://example.org/entity/lung_metastases_entity> .

<http://example.org/entity/radical_tumor_nephrectomy_entity> ns1:standard_of_care_for <http://example.org/entity/Wilms_tumor_entity> .

<http://example.org/entity/radiotherapy_guidelines_entity> ns1:specified_for <http://example.org/entity/locoregional_disease_entity>,
        <http://example.org/entity/metastatic_disease_entity> .

<http://example.org/entity/relapsed_group_CC_entity> ns1:follows <http://example.org/entity/UMBRELLA_protocol_entity> ;
    ns1:includes <http://example.org/entity/blastemal_type_tumors_entity>,
        <http://example.org/entity/diffuse_anaplasia_entity> .

<http://example.org/entity/stage_III_entity> ns1:includes_condition <http://example.org/entity/major_rupture_entity> .

<http://example.org/entity/stage_II_entity> ns1:indicated_for_in_adults <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/van_den_Heuvel_Eibrink_M_M_entity> ns1:reported_in <http://example.org/entity/SIOP_WT_2001_protocol_entity> .

<http://example.org/entity/ASCR_procedure> a ns2:procedure ;
    ns2:name "ASCR" .

<http://example.org/entity/AVD150_treatment_regimen> a ns2:treatment_regimen ;
    ns2:name "AVD150" .

<http://example.org/entity/AVD250_treatment_regimen> a ns2:treatment_regimen ;
    ns2:name "AVD250" .

<http://example.org/entity/AVD_Treatment_Combination> a ns2:Treatment_Combination ;
    ns2:name "AVD" .

<http://example.org/entity/AVD_Treatment_Group> a ns2:Treatment_Group ;
    ns2:name "AVD" .

<http://example.org/entity/AV_2_Treatment_Group> a ns2:Treatment_Group ;
    ns2:name "AV-2" .

<http://example.org/entity/AV_Treatment_Combination> a ns2:Treatment_Combination ;
    ns2:name "AV" .

<http://example.org/entity/Actinomycin_D_Drug> a ns2:Drug ;
    ns2:name "Actinomycin D" .

<http://example.org/entity/Adult_Wilms_Tumors_medical_condition> a ns2:medical_condition ;
    ns2:name "Adult Wilms Tumors" .

<http://example.org/entity/Albania_Country> a ns2:Country ;
    ns2:name "Albania" .

<http://example.org/entity/Algeria_Country> a ns2:Country ;
    ns2:name "Algeria" .

<http://example.org/entity/Andorra_Country> a ns2:Country ;
    ns2:name "Andorra" .

<http://example.org/entity/Armand_Trousseau_Hospital_Institution> a ns2:Institution ;
    ns2:name "Armand Trousseau Hospital" .

<http://example.org/entity/Aronson_et_al_Research_Group> a ns2:Research_Group ;
    ns2:name "Aronson et al." .

<http://example.org/entity/Austria_Country> a ns2:Country ;
    ns2:name "Austria" .

<http://example.org/entity/Azienda_Ospedaliera_Institution> a ns2:Institution ;
    ns2:name "Azienda Ospedaliera" .

<http://example.org/entity/Belarus_Country> a ns2:Country ;
    ns2:name "Belarus" .

<http://example.org/entity/Belgium_Country> a ns2:Country ;
    ns2:name "Belgium" .

<http://example.org/entity/Bellani_F_F_author> a ns2:author ;
    ns2:name "Bellani, F. F." .

<http://example.org/entity/Bilateral_Disease_Stage_V_Disease_Stage> a ns2:Disease_Stage ;
    ns2:name "Bilateral Disease (Stage V)" .

<http://example.org/entity/Bilateral_nephron_sparing_surgery_NSS_Treatment_Method> a ns2:Treatment_Method ;
    ns2:name "Bilateral nephron-sparing surgery (NSS)" .

<http://example.org/entity/Bosnia_and_Herzegovina_Country> a ns2:Country ;
    ns2:name "Bosnia and Herzegovina" .

<http://example.org/entity/Breslow_N_E_author> a ns2:author ;
    ns2:name "Breslow, N. E." .

<http://example.org/entity/Bulgaria_Country> a ns2:Country ;
    ns2:name "Bulgaria" .

<http://example.org/entity/CCSK_Disease> a ns2:Disease ;
    ns2:name "CCSK" .

<http://example.org/entity/CDCV_treatment_regimen> a ns2:treatment_regimen ;
    ns2:name "CDCV" .

<http://example.org/entity/CMN_Disease> a ns2:Disease ;
    ns2:name "CMN" .

<http://example.org/entity/COGNWTS_trials_trial> a ns2:trial ;
    ns2:name "COG–NWTS trials" .

<http://example.org/entity/COG_AREN0533_trial_entity> ns1:evaluates <http://example.org/entity/cumulative_doxorubicin_dose_entity> .

<http://example.org/entity/COG_AREN0533_trial_study> a ns2:study ;
    ns2:name "COG AREN0533 trial" .

<http://example.org/entity/COG_National_Wilms_Tumor_Study_Group_NWTS_4_and_NWTS_5_trials_study> a ns2:study ;
    ns2:name "COG National Wilms Tumor Study Group (NWTS)-4 and NWTS-5 trials" .

<http://example.org/entity/CT_diagnostic_tool> a ns2:diagnostic_tool ;
    ns2:name "CT" .

<http://example.org/entity/CT_only_nodules_medical_condition> a ns2:medical_condition ;
    ns2:name "CT-only nodules" .

<http://example.org/entity/Carboplatin_Drug> a ns2:Drug ;
    ns2:name "Carboplatin" .

<http://example.org/entity/Childrens_Oncology_Group_COG_Organization> a ns2:Organization ;
    ns2:name "Children’s Oncology Group (COG)" .

<http://example.org/entity/Childrens_Oncology_Group_organization> a ns2:organization ;
    ns2:name "Children’s Oncology Group" .

<http://example.org/entity/Croatia_Country> a ns2:Country ;
    ns2:name "Croatia" .

<http://example.org/entity/Cyclophosphamide_Drug> a ns2:Drug ;
    ns2:name "Cyclophosphamide" .

<http://example.org/entity/Czech_Republic_Country> a ns2:Country ;
    ns2:name "Czech Republic" .

<http://example.org/entity/DAngio_G_J_author> a ns2:author ;
    ns2:name "D'Angio, G. J." .

<http://example.org/entity/Davila_Fajardo_et_al_author> a ns2:author ;
    ns2:name "Davila Fajardo et al." .

<http://example.org/entity/Daw_N_C_author> a ns2:author ;
    ns2:name "Daw, N. C." .

<http://example.org/entity/Denmark_Country> a ns2:Country ;
    ns2:name "Denmark" .

<http://example.org/entity/Department_of_Paediatric_Oncology_Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_Institution> a ns2:Institution ;
    ns2:name "Department of Paediatric Oncology, Princess Máxima Center for Paediatric Oncology" .

<http://example.org/entity/Dix_D_B_author> a ns2:author ;
    ns2:name "Dix, D. B." .

<http://example.org/entity/Dome_J_S_author> a ns2:author ;
    ns2:name "Dome, J. S." .

<http://example.org/entity/Doxorubicin_Drug> a ns2:Drug ;
    ns2:name "Doxorubicin" .

<http://example.org/entity/End_stage_renal_disease_ESRD_Condition> a ns2:Condition ;
    ns2:name "End-stage renal disease (ESRD)" .

<http://example.org/entity/Estonia_Country> a ns2:Country ;
    ns2:name "Estonia" .

<http://example.org/entity/Etoposide_Drug> a ns2:Drug ;
    ns2:name "Etoposide" .

<http://example.org/entity/Event_Free_Survival_EFS_Subject> a ns2:Subject ;
    ns2:name "Event-Free Survival (EFS)" .

<http://example.org/entity/Event_Free_Survival_EFS_metric> a ns2:metric ;
    ns2:name "Event-Free Survival (EFS)" .

<http://example.org/entity/ExPOrNet_Project> a ns2:Project ;
    ns2:name "ExPO‑r‑Net" .

<http://example.org/entity/Faculty_of_Medicine_Institution> a ns2:Institution ;
    ns2:name "Faculty of Medicine" .

<http://example.org/entity/Finland_Country> a ns2:Country ;
    ns2:name "Finland" .

<http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Institution> a ns2:Institution ;
    ns2:name "Fondazione IRCCS Istituto Nazionale dei Tumori" .

<http://example.org/entity/France_Country> a ns2:Country ;
    ns2:name "France" .

<http://example.org/entity/Furtwangler_R_author> a ns2:author ;
    ns2:name "Furtwangler, R." .

<http://example.org/entity/Germany_Country> a ns2:Country ;
    ns2:name "Germany" .

<http://example.org/entity/Graf_N_author> a ns2:author ;
    ns2:name "Graf, N." .

<http://example.org/entity/Great_Ormond_Street_Hospital_Institution> a ns2:Institution ;
    ns2:name "Great Ormond Street Hospital" .

<http://example.org/entity/Greece_Country> a ns2:Country ;
    ns2:name "Greece" .

<http://example.org/entity/Green_D_M_author> a ns2:author ;
    ns2:name "Green, D. M." .

<http://example.org/entity/Group_AA_Patient_Group> a ns2:Patient_Group ;
    ns2:name "Group AA" .

<http://example.org/entity/Group_BB_Patient_Group> a ns2:Patient_Group ;
    ns2:name "Group BB" .

<http://example.org/entity/Group_CC_Patient_Group> a ns2:Patient_Group ;
    ns2:name "Group CC" .

<http://example.org/entity/Grundy_P_E_author> a ns2:author ;
    ns2:name "Grundy, P. E." .

<http://example.org/entity/HR_1_Treatment_Combination> a ns2:Treatment_Combination ;
    ns2:name "HR-1" .

<http://example.org/entity/Ha_T_C_author> a ns2:author ;
    ns2:name "Ha, T. C." .

<http://example.org/entity/High_dose_melphalan_Treatment_Method> a ns2:Treatment_Method ;
    ns2:name "High-dose melphalan" .

<http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Institution> a ns2:Institution ;
    ns2:name "Hospital Universitario Virgin del Rocio" .

<http://example.org/entity/Hospital_Vall_dHebron_Institution> a ns2:Institution ;
    ns2:name "Hospital Vall d’Hebron" .

<http://example.org/entity/Hungary_Country> a ns2:Country ;
    ns2:name "Hungary" .

<http://example.org/entity/Iceland_Country> a ns2:Country ;
    ns2:name "Iceland" .

<http://example.org/entity/Ifosfamide_Drug> a ns2:Drug ;
    ns2:name "Ifosfamide" .

<http://example.org/entity/Infant_Wilms_Tumors_medical_condition> a ns2:medical_condition ;
    ns2:name "Infant Wilms Tumors" .

<http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_organization> a ns2:organization ;
    ns2:name "Innovative Therapies for Children with Cancer consortium" .

<http://example.org/entity/Ireland_Country> a ns2:Country ;
    ns2:name "Ireland" .

<http://example.org/entity/Italy_Country> a ns2:Country ;
    ns2:name "Italy" .

<http://example.org/entity/Kremens_B_author> a ns2:author ;
    ns2:name "Kremens, B." .

<http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Institution> a ns2:Institution ;
    ns2:name "L’Institut d’Hématologie et d’Oncologie Pédiatrique de Lyon" .

<http://example.org/entity/Latvia_Country> a ns2:Country ;
    ns2:name "Latvia" .

<http://example.org/entity/Liechtenstein_Country> a ns2:Country ;
    ns2:name "Liechtenstein" .

<http://example.org/entity/Lithuania_Country> a ns2:Country ;
    ns2:name "Lithuania" .

<http://example.org/entity/LogRank_P_Statistical_Test> a ns2:Statistical_Test ;
    ns2:name "Log–Rank P" .

<http://example.org/entity/Luxembourg_Country> a ns2:Country ;
    ns2:name "Luxembourg" .

<http://example.org/entity/MRI_diagnostic_tool> a ns2:diagnostic_tool ;
    ns2:name "MRI" .

<http://example.org/entity/MRTK_Disease> a ns2:Disease ;
    ns2:name "MRTK" .

<http://example.org/entity/Macedonia_Country> a ns2:Country ;
    ns2:name "Macedonia" .

<http://example.org/entity/Malta_Country> a ns2:Country ;
    ns2:name "Malta" .

<http://example.org/entity/Marciniak_Hospital_Institution> a ns2:Institution ;
    ns2:name "Marciniak Hospital" .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_Person> a ns2:Person ;
    ns2:name "Marry M. van den Heuvel-Eibrink" .

<http://example.org/entity/Mitchell_C_author> a ns2:author ;
    ns2:name "Mitchell, C." .

<http://example.org/entity/Moldova_Country> a ns2:Country ;
    ns2:name "Moldova" .

<http://example.org/entity/Monaco_Country> a ns2:Country ;
    ns2:name "Monaco" .

<http://example.org/entity/Montenegro_Country> a ns2:Country ;
    ns2:name "Montenegro" .

<http://example.org/entity/Morocco_Country> a ns2:Country ;
    ns2:name "Morocco" .

<http://example.org/entity/NWTS5_relapse_protocol_Treatment_Protocol> a ns2:Treatment_Protocol ;
    ns2:name "NWTS‑5 relapse protocol" .

<http://example.org/entity/National_Wilms_Tumor_Studies_study> a ns2:study ;
    ns2:name "National Wilms Tumor Studies" .

<http://example.org/entity/National_Wilms_Tumor_Study_Group_organization> a ns2:organization ;
    ns2:name "National Wilms Tumor Study Group" .

<http://example.org/entity/Nephron_sparing_surgery_NSS_surgical_procedure> a ns2:surgical_procedure ;
    ns2:name "Nephron-sparing surgery (NSS)" .

<http://example.org/entity/Netherlands_Country> a ns2:Country ;
    ns2:name "Netherlands" .

<http://example.org/entity/Ninth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_study> a ns2:study ;
    ns2:name "Ninth International Society of Pediatric Oncology Wilms’ Tumor Trial and Study" .

<http://example.org/entity/Norway_Country> a ns2:Country ;
    ns2:name "Norway" .

<http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Institution> a ns2:Institution ;
    ns2:name "Ospedale Pediatrico Bambino Gesù" .

<http://example.org/entity/Overall_Survival_OS_Subject> a ns2:Subject ;
    ns2:name "Overall Survival (OS)" .

<http://example.org/entity/Overall_Survival_OS_metric> a ns2:metric ;
    ns2:name "Overall Survival (OS)" .

<http://example.org/entity/Poland_Country> a ns2:Country ;
    ns2:name "Poland" .

<http://example.org/entity/Portugal_Country> a ns2:Country ;
    ns2:name "Portugal" .

<http://example.org/entity/Prinses_Maxima_Centrum_Institution> a ns2:Institution ;
    ns2:name "Prinses Maxima Centrum" .

<http://example.org/entity/Pritchard_Jones_K_author> a ns2:author ;
    ns2:name "Pritchard-Jones, K." .

<http://example.org/entity/RCC_Disease> a ns2:Disease ;
    ns2:name "RCC" .

<http://example.org/entity/Relapsed_Wilms_Tumor_Disease_State> a ns2:Disease_State ;
    ns2:name "Relapsed Wilms Tumor" .

<http://example.org/entity/Romania_Country> a ns2:Country ;
    ns2:name "Romania" .

<http://example.org/entity/Russia_Country> a ns2:Country ;
    ns2:name "Russia" .

<http://example.org/entity/SIOP2001_Protocol> a ns2:Protocol ;
    ns2:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_Trial> a ns2:Trial ;
    ns2:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_protocol> a ns2:protocol ;
    ns2:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_randomized_trial_Clinical_Trial> a ns2:Clinical_Trial ;
    ns2:name "SIOP−2001 randomized trial" .

<http://example.org/entity/SIOP2001_randomized_trial_entity> ns1:investigated_use_in <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/SIOP2001_study_Study> a ns2:Study ;
    ns2:name "SIOP−2001 study" .

<http://example.org/entity/SIOP2001_study_protocol> a ns2:study_protocol ;
    ns2:name "SIOP−2001" .

<http://example.org/entity/SIOPRTSG_Organization> a ns2:Organization ;
    ns2:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_analysis_study> a ns2:study ;
    ns2:name "SIOP–RTSG analysis" .

<http://example.org/entity/SIOPRTSG_board_organization> a ns2:organization ;
    ns2:name "SIOP–RTSG board" .

<http://example.org/entity/SIOPRTSG_organization> a ns2:organization ;
    ns2:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_panel_organization> a ns2:organization ;
    ns2:name "SIOP−RTSG panel" .

<http://example.org/entity/SIOP_9301_trial_trial> a ns2:trial ;
    ns2:name "SIOP 93–01 trial" .

<http://example.org/entity/SIOP_9GPOH_study> a ns2:study ;
    ns2:name "SIOP-9/GPOH" .

<http://example.org/entity/SIOP_RTSG_2016_Protocol> a ns2:Protocol ;
    ns2:name "SIOP-RTSG 2016" .

<http://example.org/entity/SIOP_WT_2001_protocol_protocol> a ns2:protocol ;
    ns2:name "SIOP WT 2001 protocol" .

<http://example.org/entity/SIOP_database_database> a ns2:database ;
    ns2:name "SIOP database" .

<http://example.org/entity/SIOP_trial_and_study_9301_study> a ns2:study ;
    ns2:name "SIOP trial and study 93–01" .

<http://example.org/entity/San_Marino_Country> a ns2:Country ;
    ns2:name "San Marino" .

<http://example.org/entity/Second_National_Wilms_Tumor_Study_study> a ns2:study ;
    ns2:name "Second National Wilms’ Tumor Study" .

<http://example.org/entity/Serbia_Country> a ns2:Country ;
    ns2:name "Serbia" .

<http://example.org/entity/Sixth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_study> a ns2:study ;
    ns2:name "Sixth International Society of Pediatric Oncology Wilms’ Tumor Trial and Study" .

<http://example.org/entity/Slovakia_Country> a ns2:Country ;
    ns2:name "Slovakia" .

<http://example.org/entity/Slovenia_Country> a ns2:Country ;
    ns2:name "Slovenia" .

<http://example.org/entity/Smets_A_M_author> a ns2:author ;
    ns2:name "Smets, A. M." .

<http://example.org/entity/Spain_Country> a ns2:Country ;
    ns2:name "Spain" .

<http://example.org/entity/Spreafico_F_author> a ns2:author ;
    ns2:name "Spreafico, F." .

<http://example.org/entity/St_Anna_KinderspitalCCRI_Institution> a ns2:Institution ;
    ns2:name "St. Anna Kinderspital/CCRI" .

<http://example.org/entity/Stage_III_Stage> a ns2:Stage ;
    ns2:name "Stage III" .

<http://example.org/entity/Stage_III_entity> ns1:treated_with <http://example.org/entity/vincestine_and_actinomycin_D_entity> .

<http://example.org/entity/Stage_II_Stage> a ns2:Stage ;
    ns2:name "Stage II" .

<http://example.org/entity/Stage_II_entity> ns1:treated_with <http://example.org/entity/vincestine_and_actinomycin_D_entity> .

<http://example.org/entity/Stage_IV_Stage> a ns2:Stage ;
    ns2:name "Stage IV" .

<http://example.org/entity/Stage_I_Stage> a ns2:Stage ;
    ns2:name "Stage I" .

<http://example.org/entity/Stage_V_Stage> a ns2:Stage ;
    ns2:name "Stage V" .

<http://example.org/entity/Sweden_Country> a ns2:Country ;
    ns2:name "Sweden" .

<http://example.org/entity/Switzerland_Country> a ns2:Country ;
    ns2:name "Switzerland" .

<http://example.org/entity/Synchronous_bilateral_Wilms_tumor_Disease> a ns2:Disease ;
    ns2:name "Synchronous bilateral Wilms tumor" .

<http://example.org/entity/The_Renal_Tumour_Study_Group_of_the_International_Society_of_Paediatric_Oncology_SIOPRTSG_Organization> a ns2:Organization ;
    ns2:name "The Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP–RTSG)" .

<http://example.org/entity/Third_National_Wilms_Tumor_Study_study> a ns2:study ;
    ns2:name "Third National Wilms’ Tumor Study" .

<http://example.org/entity/Tournade_M_F_author> a ns2:author ;
    ns2:name "Tournade, M. F." .

<http://example.org/entity/Tunisia_Country> a ns2:Country ;
    ns2:name "Tunisia" .

<http://example.org/entity/Turkey_Country> a ns2:Country ;
    ns2:name "Turkey" .

<http://example.org/entity/UKW3_trial> a ns2:trial ;
    ns2:name "UKW3" .

<http://example.org/entity/UKW3_trial_Clinical_Trial> a ns2:Clinical_Trial ;
    ns2:name "UKW3 trial" .

<http://example.org/entity/UKW3_trial_entity> ns1:validated_use_of <http://example.org/entity/actinomycin_D_entity>,
        <http://example.org/entity/vincristine_entity> .

<http://example.org/entity/UKWR_protocol_Treatment_Protocol> a ns2:Treatment_Protocol ;
    ns2:name "UKW‑R protocol" .

<http://example.org/entity/UK_Childrens_Cancer_Study_Group_organization> a ns2:organization ;
    ns2:name "UK Children’s Cancer Study Group" .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_Organization> a ns2:Organization ;
    ns2:name "UK Children’s Cancer and Leukaemia Group (UKCCLG)" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_Protocol> a ns2:Protocol ;
    ns2:name "UMBRELLA SIOP-RTSG 2016" .

<http://example.org/entity/UMBRELLA_protocol_Project> a ns2:Project ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_Protocol> a ns2:Protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_Treatment_Protocol> a ns2:Treatment_Protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_protocol> a ns2:protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_treatment_protocol> a ns2:treatment_protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/Ukraine_Country> a ns2:Country ;
    ns2:name "Ukraine" .

<http://example.org/entity/United_Kingdom_Country> a ns2:Country ;
    ns2:name "United Kingdom" .

<http://example.org/entity/University_Hospital_Homburg_Institution> a ns2:Institution ;
    ns2:name "University Hospital Homburg" .

<http://example.org/entity/University_Hospital_of_Munich_Institution> a ns2:Institution ;
    ns2:name "University Hospital of Munich" .

<http://example.org/entity/University_Hospital_of_Tuebingen_Institution> a ns2:Institution ;
    ns2:name "University Hospital of Tuebingen" .

<http://example.org/entity/VP16_medication> a ns2:medication ;
    ns2:name "VP16" .

<http://example.org/entity/Verschuur_A_author> a ns2:author ;
    ns2:name "Verschuur, A." .

<http://example.org/entity/Vincristine_Drug> a ns2:Drug ;
    ns2:name "Vincristine" .

<http://example.org/entity/Warmann_S_W_author> a ns2:author ;
    ns2:name "Warmann, S. W." .

<http://example.org/entity/Weirich_A_author> a ns2:author ;
    ns2:name "Weirich, A." .

<http://example.org/entity/Wilms_Tumour_Disease> a ns2:Disease ;
    ns2:name "Wilms Tumour" .

<http://example.org/entity/Wilms_tumours_Condition> a ns2:Condition ;
    ns2:name "Wilms tumours" .

<http://example.org/entity/Wilms_tumours_Disease> a ns2:Disease ;
    ns2:name "Wilms tumours" .

<http://example.org/entity/Wilms_tumours_condition> a ns2:condition ;
    ns2:name "Wilms tumours" .

<http://example.org/entity/actinomycin_D_Drug> a ns2:Drug ;
    ns2:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_Treatment> a ns2:Treatment ;
    ns2:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_drug> a ns2:drug ;
    ns2:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_medication> a ns2:medication ;
    ns2:name "actinomycin-D" .

<http://example.org/entity/anaplasia_entity> ns1:treatment_includes <http://example.org/entity/carboplatin_entity>,
        <http://example.org/entity/cyclophosphamide_entity>,
        <http://example.org/entity/etoposide_entity> .

<http://example.org/entity/anaplasia_medical_condition> a ns2:medical_condition ;
    ns2:name "anaplasia" .

<http://example.org/entity/arnauldverschuurap_hmfr_contact> a ns2:contact ;
    ns2:name "arnauld.verschuur@ap-hm.fr" .

<http://example.org/entity/bilateral_disease_Disease_Stage> a ns2:Disease_Stage ;
    ns2:name "bilateral disease" .

<http://example.org/entity/blastemal_type_Wilms_tumours_Subtype> a ns2:Subtype ;
    ns2:name "blastemal-type Wilms tumours" .

<http://example.org/entity/blastemal_type_tumors_condition> a ns2:condition ;
    ns2:name "blastemal-type tumors" .

<http://example.org/entity/camptothecins_medication_class> a ns2:medication_class ;
    ns2:name "camptothecins" .

<http://example.org/entity/carboplatin_Treatment> a ns2:Treatment ;
    ns2:name "carboplatin" .

<http://example.org/entity/carboplatin_drug> a ns2:drug ;
    ns2:name "carboplatin" .

<http://example.org/entity/carboplatin_medication> a ns2:medication ;
    ns2:name "carboplatin" .

<http://example.org/entity/chemotherapy_Treatment_Method> a ns2:Treatment_Method ;
    ns2:name "chemotherapy" .

<http://example.org/entity/chemotherapy_treatment_method> a ns2:treatment_method ;
    ns2:name "chemotherapy" .

<http://example.org/entity/childhood_renal_tumours_Disease> a ns2:Disease ;
    ns2:name "childhood renal tumours" .

<http://example.org/entity/clear_cell_sarcoma_of_the_kidney_Disease> a ns2:Disease ;
    ns2:name "clear cell sarcoma of the kidney" .

<http://example.org/entity/congenital_mesoblastic_nephroma_Disease> a ns2:Disease ;
    ns2:name "congenital mesoblastic nephroma" .

<http://example.org/entity/congenital_mesoblastic_nephroma_medical_condition> a ns2:medical_condition ;
    ns2:name "congenital mesoblastic nephroma" .

<http://example.org/entity/cumulative_doxorubicin_dose_treatment_detail> a ns2:treatment_detail ;
    ns2:name "cumulative doxorubicin dose" .

<http://example.org/entity/cyclophosphamide_Treatment> a ns2:Treatment ;
    ns2:name "cyclophosphamide" .

<http://example.org/entity/cyclophosphamide_drug> a ns2:drug ;
    ns2:name "cyclophosphamide" .

<http://example.org/entity/cyclophosphamide_medication> a ns2:medication ;
    ns2:name "cyclophosphamide" .

<http://example.org/entity/de_Kraker_J_author> a ns2:author ;
    ns2:name "de Kraker, J." .

<http://example.org/entity/diffuse_anaplasia_condition> a ns2:condition ;
    ns2:name "diffuse anaplasia" .

<http://example.org/entity/dosimetric_study_study> a ns2:study ;
    ns2:name "dosimetric study" .

<http://example.org/entity/doxorubicin_Drug> a ns2:Drug ;
    ns2:name "doxorubicin" .

<http://example.org/entity/doxorubicin_Treatment> a ns2:Treatment ;
    ns2:name "doxorubicin" .

<http://example.org/entity/doxorubicin_drug> a ns2:drug ;
    ns2:name "doxorubicin" .

<http://example.org/entity/doxorubicin_medication> a ns2:medication ;
    ns2:name "doxorubicin" .

<http://example.org/entity/etoposide_Treatment> a ns2:Treatment ;
    ns2:name "etoposide" .

<http://example.org/entity/etoposide_drug> a ns2:drug ;
    ns2:name "etoposide" .

<http://example.org/entity/etoposide_medication> a ns2:medication ;
    ns2:name "etoposide" .

<http://example.org/entity/high_dose_chemotherapy_and_autologous_stem_cell_transplantation_treatment> a ns2:treatment ;
    ns2:name "high-dose chemotherapy and autologous stem cell transplantation" .

<http://example.org/entity/high_risk_characteristics_medical_condition> a ns2:medical_condition ;
    ns2:name "high-risk characteristics" .

<http://example.org/entity/high_risk_disease_condition_category> a ns2:condition_category ;
    ns2:name "high-risk disease" .

<http://example.org/entity/high_risk_risk_category> a ns2:risk_category ;
    ns2:name "high-risk" .

<http://example.org/entity/ifosfamide_medication> a ns2:medication ;
    ns2:name "ifosfamide" .

<http://example.org/entity/intermediate_risk_disease_condition_category> a ns2:condition_category ;
    ns2:name "intermediate-risk disease" .

<http://example.org/entity/intermediate_risk_risk_category> a ns2:risk_category ;
    ns2:name "intermediate-risk" .

<http://example.org/entity/irinotecan_medication> a ns2:medication ;
    ns2:name "irinotecan" .

<http://example.org/entity/laparoscopic_surgery_surgery_type> a ns2:surgery_type ;
    ns2:name "laparoscopic surgery" .

<http://example.org/entity/localized_disease_Disease_Stage> a ns2:Disease_Stage ;
    ns2:name "localized disease" .

<http://example.org/entity/locoregional_disease_condition> a ns2:condition ;
    ns2:name "locoregional disease" .

<http://example.org/entity/low_risk_disease_condition_category> a ns2:condition_category ;
    ns2:name "low-risk disease" .

<http://example.org/entity/low_risk_risk_category> a ns2:risk_category ;
    ns2:name "low-risk" .

<http://example.org/entity/lymph_node_sampling_surgical_procedure> a ns2:surgical_procedure ;
    ns2:name "lymph node sampling" .

<http://example.org/entity/major_rupture_condition> a ns2:condition ;
    ns2:name "major rupture" .

<http://example.org/entity/malignant_rhabdoid_tumors_medical_condition> a ns2:medical_condition ;
    ns2:name "malignant rhabdoid tumors" .

<http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_Disease> a ns2:Disease ;
    ns2:name "malignant rhabdoid tumour of the kidney" .

<http://example.org/entity/metastatic_disease_Disease_Stage> a ns2:Disease_Stage ;
    ns2:name "metastatic disease" .

<http://example.org/entity/metastatic_disease_condition> a ns2:condition ;
    ns2:name "metastatic disease" .

<http://example.org/entity/minimally_invasive_surgery_surgery_type> a ns2:surgery_type ;
    ns2:name "minimally invasive surgery" .

<http://example.org/entity/nephrectomy_surgical_procedure> a ns2:surgical_procedure ;
    ns2:name "nephrectomy" .

<http://example.org/entity/nephron_sparing_surgery_NSS_surgery_type> a ns2:surgery_type ;
    ns2:name "nephron-sparing surgery (NSS)" .

<http://example.org/entity/nephrotoxicity_condition> a ns2:condition ;
    ns2:name "nephrotoxicity" .

<http://example.org/entity/non_Wilms_tumours_Disease> a ns2:Disease ;
    ns2:name "non-Wilms tumours" .

<http://example.org/entity/proton_therapy_entity> ns1:suggested_for <http://example.org/entity/flank_irradiation_entity> .

<http://example.org/entity/proton_therapy_treatment> a ns2:treatment ;
    ns2:name "proton therapy" .

<http://example.org/entity/pulmonary_radiotherapy_treatment> a ns2:treatment ;
    ns2:name "pulmonary radiotherapy" .

<http://example.org/entity/radical_tumor_nephrectomy_surgical_procedure> a ns2:surgical_procedure ;
    ns2:name "radical tumor nephrectomy" .

<http://example.org/entity/radiotherapy_Treatment_Method> a ns2:Treatment_Method ;
    ns2:name "radiotherapy" .

<http://example.org/entity/radiotherapy_treatment> a ns2:treatment ;
    ns2:name "radiotherapy" .

<http://example.org/entity/radiotherapy_treatment_method> a ns2:treatment_method ;
    ns2:name "radiotherapy" .

<http://example.org/entity/relapsed_disease_Disease_Stage> a ns2:Disease_Stage ;
    ns2:name "relapsed disease" .

<http://example.org/entity/relapsed_group_CC_patient_group> a ns2:patient_group ;
    ns2:name "relapsed group CC" .

<http://example.org/entity/renal_cell_carcinoma_Disease> a ns2:Disease ;
    ns2:name "renal cell carcinoma" .

<http://example.org/entity/stage_III_stage> a ns2:stage ;
    ns2:name "stage III" .

<http://example.org/entity/stage_II_stage> a ns2:stage ;
    ns2:name "stage II" .

<http://example.org/entity/stage_IV_WT_condition> a ns2:condition ;
    ns2:name "stage IV WT" .

<http://example.org/entity/stage_I_stage> a ns2:stage ;
    ns2:name "stage I" .

<http://example.org/entity/surgery_Treatment_Method> a ns2:Treatment_Method ;
    ns2:name "surgery" .

<http://example.org/entity/surgery_entity> ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/surgery_treatment_method> a ns2:treatment_method ;
    ns2:name "surgery" .

<http://example.org/entity/surgical_excision_treatment_method> a ns2:treatment_method ;
    ns2:name "surgical excision" .

<http://example.org/entity/topotecan_medication> a ns2:medication ;
    ns2:name "topotecan" .

<http://example.org/entity/van_den_Heuvel_Eibrink_M_M_author> a ns2:author ;
    ns2:name "van den Heuvel-Eibrink, M. M." .

<http://example.org/entity/vincristine_Drug> a ns2:Drug ;
    ns2:name "vincristine" .

<http://example.org/entity/vincristine_Treatment> a ns2:Treatment ;
    ns2:name "vincristine" .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment> a ns2:treatment ;
    ns2:name "vincristine and actinomycin D plus doxorubicin" .

<http://example.org/entity/vincristine_and_actinomycin_D_treatment> a ns2:treatment ;
    ns2:name "vincristine and actinomycin D" .

<http://example.org/entity/vincristine_drug> a ns2:drug ;
    ns2:name "vincristine" .

<http://example.org/entity/vincristine_irinotecan_cyclophosphamide_carboplatin_etoposide_and_doxorubicin_treatment> a ns2:treatment ;
    ns2:name "vincristine, irinotecan, cyclophosphamide, carboplatin, etoposide, and doxorubicin" .

<http://example.org/entity/vincristine_medication> a ns2:medication ;
    ns2:name "vincristine" .

<http://example.org/entity/whole_lung_irradiation_treatment> a ns2:treatment ;
    ns2:name "whole-lung irradiation" .

<http://example.org/entity/wwwsiop_rtsgeu_Website> a ns2:Website ;
    ns2:name "www.siop-rtsg.eu" .

<http://example.org/entity/Relapsed_Wilms_Tumor_entity> ns1:guided_by <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/SIOPRTSG_entity> ns1:aims_to_improve_survival_rates_of <http://example.org/entity/Wilms_tumor_entity> ;
    ns1:developed <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/radiotherapy_entity> ns1:contact_for_guidance <http://example.org/entity/SIOPRTSG_panel_entity> ;
    ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/actinomycin_D_entity> ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/vincristine_entity> ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/SIOP2001_entity> ns1:provided_guidelines_for <http://example.org/entity/radiotherapy_entity> ;
    ns1:uses <http://example.org/entity/vincristine_actinomycin_D_and_doxorubicin_entity> .

<http://example.org/entity/doxorubicin_entity> ns1:recommended_for <http://example.org/entity/large_volume_tumours_entity> ;
    ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/UMBRELLA_protocol_entity> ns1:adopts_treatment_regimen_from <http://example.org/entity/SIOP2001_entity> ;
    ns1:advises_treatment_for <http://example.org/entity/Bilateral_Disease_Stage_V_entity> ;
    ns1:collaborates_with <http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_entity> ;
    ns1:follows <http://example.org/entity/SIOP2001_entity> ;
    ns1:guides_treatment_in <http://example.org/entity/Wilms_tumor_entity> ;
    ns1:is_the_standard_of <http://example.org/entity/SIOPRTSG_entity> ;
    ns1:provides_guidelines_for <http://example.org/entity/radiotherapy_entity>,
        <http://example.org/entity/surgery_entity> ;
    ns1:uses_data_from <http://example.org/entity/COG_AREN0533_trial_entity> .

<http://example.org/entity/Wilms_tumours_entity> ns1:category_of <http://example.org/entity/childhood_renal_tumours_entity> ;
    ns1:treated_under <http://example.org/entity/UMBRELLA_protocol_entity> .

